Published in Pharma Law Weekly, July 14th, 2009
"Fluorogenic caspase-3 Substrates were prepared by conjugating the quencher, IRDye((R)) QC-1, to a GDEVDGAK peptide in combination with fluorescein (emission maximum similar to 540 nm), Cy3 (similar to 570 nm), Cy5 (similar to 670 nm), IRDye 680 (similar to 700 nm), IRDye 700DX (similar to 690 mn), or IRDye 800CW (similar...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly